Versant Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Versant Capital Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Buy	7 +4	+133%	+$1.18K	﹤0.01%	2560
2026 Q1	$891	Buy	+3	New	+$971	﹤0.01%	2665
2023 Q4	–	Sell	-8	Closed	-$1.44K	–	2028
2023 Q3	$1.44K	Hold	8	–	–	﹤0.01%	1417
2023 Q2	$1.43K	Hold	8	–	–	﹤0.01%	1498
2023 Q1	$1.72K	Buy	+8	New	+$1.92K	﹤0.01%	1307

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Versant Capital Management's ONC Position: Q2 2026 in Review

Versant Capital Management increased its BeOne Medicines Ltd (ONC) stake by 133% in Q2 2026, buying an estimated $1.18K and bringing the position to 7 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2560.

Versant Capital Management first reported a position in ONC in Q1 2023 and has held it in 5 quarters since. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Versant Capital Management held 7 shares of BeOne Medicines Ltd worth $2K as of Q2 2026.
Versant Capital Management bought 4 BeOne Medicines Ltd shares in Q2 2026, an estimated $1.18K.
BeOne Medicines Ltd made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2560 holding.
Versant Capital Management first reported a position in BeOne Medicines Ltd in Q1 2023 and has held it in 5 quarters since.
283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.